Background Age and body mass index (BMI) are positively associated with the development of the metabolic syndrome (MetS). Cardiorespiratory fitness (CRF) can attenuate BMI-related increases in prevalence of MetS, but the nature of this association across different age strata has not been fully investigated. Aim To identify the association between CRF and MetS prevalence across age strata (20-69 years) and determine whether associations are independent of BMI. Methods CRF was estimated from incremental treadmill exercise in British men attending preventative health screening. Participants were placed in four age strata (20-39, 40-49, 50-59 and 60-69 years) and classified as fit or unfit using age-related cut-offs. The presence of MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria. Results 9666 asymptomatic men (48.7±8.4 years) were enrolled. The prevalence of MetS was 25.5% in all men and ranged from 17.1% in those aged 20-39 years to 30.6% in those aged 60-69 years. Fit men's likelihood of meeting the criteria for MetS was half (OR=0.51, 95% CI 0.46 to 0.57) that of unfit men. The likelihood of MetS was 32-53% lower across age strata in fit, compared with unfit men. Adjustment for BMI attenuated the association, though it remained significant in men aged 20-49 years. Conclusions The cardiometabolic benefits of CRF are independent of BMI particularly in men <50 years. Public health messages should emphasise the important role of CRF alongside weight management for enhancing cardiometabolic health.
INTRODUCTION
Adults with low cardiorespiratory fitness (CRF) have an increased risk of premature all-cause (70%) and cardiovascular mortality (56%) compared with the highest. 1 Despite the potential value of exercise testing in health surveillance and preventive healthcare, 2 CRF is not routinely assessed in UK health surveys, nor employed in health screening. Screening relies on identifying the presence and clustering of traditional cardiovascular disease risk factors. These factors may indicate a prediabetic state, termed the metabolic syndrome (MetS). The health implications 3 correlates 4 and antecedents 5 of MetS are well described elsewhere. In the UK, the ageing population continues to see rises in body mass index (BMI) 6 which indicates that prevalence of MetS may increase in years to come if left unchecked.
The protection afforded by CRF occurs in a dose-dependent fashion. 6 CRF can attenuate MetS risk [7] [8] [9] [10] but data describing CRF in UK adults are sparse. 11 The Aerobic Center Longitudinal Study based at the Cooper Clinic is perhaps the largest source of data showing the cross-sectional relationship between CRF and cardiometabolic risk. 12 Earnest and colleagues 12 demonstrated that in 38 659 males and females, CRF demonstrated a strong inverse relationship with MetS after adjustment for BMI, smoking status, alcohol intake and family history of cardiovascular disease. We aimed to determine the association between CRF and the prevalence of MetS across different age strata of asymptomatic British men. These data are important as it is necessary to ascertain whether the strong inverse associations between CRF and MetS are maintained across the lifespan. We also attempted to determine the degree to which the association was independent from BMI.
METHODS
Ethical approval was granted by the Faculty of Society and Health Ethics Committee, Buckinghamshire New University. Participants (aged 20-69 years) attended one of five Health and Wellbeing clinics around the UK for a 3-hour preventative health assessment between 2000 and 2009. Participants attended general health examinations as an annual benefit provided by their corporate wellness schemes. Each participant was instructed in their preassessment information pack to avoid any form of vigorous physical activity, alcohol and/or caffeinated beverages within the 24 hours prior to their assessment. Each participant signed and consented to the test battery and use of their data for research purposes.
Anthropometric measurements
Body mass was measured using digital scales (Marsden, UK) and recorded to the nearest 0.1 kg. Clothing was worn but shoes and belts were removed, and participants evacuated their bladder before stepping onto the scales. Scales were calibrated daily with a known weight and biannually by the manufacturer. Stature was measured using a stadiometer (Seca, Hamburg, Germany) and recorded to the nearest 0.1 cm. Participants removed their shoes, stood on the stadiometer platform with feet together and head in the Frankfort plane. Buttocks and scapulae were in contact with the back of the stadiometer, shoulders relaxed with hands and arms loosely to the sides, the measurement was taken on full inhalation. BMI was subsequently reported as kg/m 2 , then categorised into underweight (n=4, cases removed), normal weight (18.5-24.9 kg/ m 2 ), overweight (25-29.9 kg/m 2 ) and obese (≥30 kg/m 2 ). 13 Waist circumference (WC) was measured using a standard anthropometric flexible tape measure (Seca, Birmingham, UK), at minimal inspiration to the nearest 0.1 cm, midway between the lowest rib and the iliac crest, which corresponded with the umbilical level in most participants.
Venous blood sampling
Participants presented in a fasted state (for the previous 12 hours) but ate a snack (fruit or muesli bar) prior to the exercise test. At the start of each assessment, fasted venous blood samples were obtained using vacutainer tubes and heparinised whole blood was analysed using the Piccolo blood chemistry analyser (Abaxis, USA). The following analytes were measured: glucose, total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides and TC/HDL ratio.
Exercise tolerance test
Resting blood pressure was measured using a manual system (Accoson Duplex Aneroid Model, AC Cosser & Son, UK). Participants positioned themselves on the T2100 treadmill (GE Healthcare, UK) and undertook an incremental exercise test using the Bruce protocol. Blood pressure was monitored at the second minute of each stage using the automated Tango stress test monitor (Suntech Medical, Oxfordshire, UK). Rating of perceived exertion (RPE) was recorded at the end of each stage using the 6-20 Borg Scale. The ECG was monitored throughout the test. Participants exercised until they attained ≥85% of their age-predicted maximum heart rate determined by the 220-age formula or met any of the American College of Sports Medicine (ACSM) termination criteria. Peak oxygen uptake was estimated and reported in mL/kg/min. 14 Data were categorised by 10-year age strata, and peak oxygen uptake (mL/kg/min) was classified as 'Fit' or 'Unfit' based on the Cooper Institute age-specific and sex-specific cut-offs for CRF. 15 
Data treatment
All participants with a diagnosis of cardiometabolic disease were excluded from the analysis. We defined the presence of MetS using the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria: 16 Data analysis SPSS V.22.0 (SPSS an IBM Company, IBM, New York, USA) was used to analyse the data. An α level of p<0.05 was accepted as significant. All variables were checked for normality using Kolmogorov-Smirnov tests. All continuous variables in table 1 were normally distributed. Descriptive statistics were performed to identify means, SD and 95% CIs. Area-level deprivation was determined by home postal codes using the English Indices of Deprivation (EID). 17 A higher EID is indicative of a more deprived lower super output area. We compared sociodemographic and anthropometric values between participants classified as 'Fit' (vs 'Unfit') using independent t-tests for continuous variables and using χ 2 tests for categorical variables. We compared the prevalence of MetS components categorised as present across age groups using χ 2 test and one-way analysis of variance. The number of MetS components present between age groups was analysed using the Kruskal-Wallis h-test. We used binary logistic regression analysis to determine the likelihood of a diagnosis of MetS within each age strata according to CRF. Using 'Unfit' as the referent category, we calculated the odds (OR; 95% CI) of presence of MetS within each age strata in participants classified as 'Fit'. These estimates were adjusted for smoking status, area-level deprivation and BMI. We also examined prevalence of MetS (%) based on a quintile distribution of CRF (figure 1).
RESULTS
A total of 9666 asymptomatic men (48.7±8.4 years) were enrolled. Mean estimated peak oxygen uptake was 38.7 (±9.9) mL/kg/min and 23.8% (n=2401) of participants were classified as unfit (table 1) . More than half (54%) of the sample were overweight and a further 18% were obese. Unfit men had significantly higher WC, blood pressure, plasma triglycerides and lower levels of plasma HDL (all p<0.001). Fasting plasma glucose ( p=0.075) and LDL ( p=0.605) did not differ significantly according to CRF. Table 2 shows that 25.5% of all participants met the criteria for MetS, but prevalence varied by age group from 17.1% in those aged 20-39 years, to 30.6% in the 60-69 years category. When presenting prevalence (%) of MetS based on a quintile distribution of CRF (figure 1), we noted an inverse linear association. MetS prevalence was 33.1% in the least fit group which reduced in a stepwise manner to the highest fit group ( prevalence 16.5%, OR=0.71 (95% CI 0.61 to 0.83), p<0.001) after adjustment for age and BMI.
Across all ages, the likelihood of MetS was significantly lower (OR=0.51, 95% CI 0.46 to 0.57) in fit men. After adjusting for age, deprivation index, smoking status and BMI; the likelihood of MetS in fit men remained lower than those who were unfit (OR=0.73; 95% CI 0.65 to 0.82; table 3). Being classified as 'Fit' significantly reduced the likelihood of MetS across the majority of age strata with or without additional adjustment for BMI. Applying Model 1 in men aged 60-69 years, being 'Fit' was associated with a 32% lower odds of MetS (OR=0.68, 95% CI 0.48 to 0.98; p=0.004), but when this estimate was corrected for BMI (Model 2), there was no longer a significant difference in the likelihood of MetS in this age strata (p=0.319).
DISCUSSION
More than one quarter (25.5%) of 9666 asymptomatic males comprising our sample met the ATP III criteria 15 for the presence of the MetS, comparable with estimates (29-34%) from representative samples of US adult men. 18 The prevalence of MetS was higher than has been reported previously in UK adults. Brunner et al 4 reported that 11.7% of civil servants (age 30-63 years) surveyed between 1991 and 1993 met their definition of MetS. Hyppönen et al 19 identified MetS in 9.7% of (n=6810) 45-year-old men with a prevalence of overweight and obesity comparable with that of the present study. Neither study included objective assessments of CRF or physical activity. Hyppönen et al 19 found self-reported physical activity was negatively associated with MetS, whereas Brunner et al 4 found no significant association. Neither of these large cohort studies examined the role of CRF.
Cardiorespiratory fitness and metabolic syndrome
Fit men had significantly lower mean values for all MetS components (except glucose, p=0.075), fewer cardiometabolic risk factors and had a lower prevalence of MetS when compared with men classified unfit. The association between CRF and MetS remained significant when adjusting for BMI. 10 LaMonte et al 8 found MetS incidence was 53% lower in men within the highest tertile of CRF compared with the least fit. This estimate was not adjusted for BMI but can be compared with our unadjusted estimate of 49%. Incidence of MetS in the oldest group (60-69 years) was nearly double that of the youngest participants (20-29 years) , and there was a significant increase in each MetS component across age strata. Our findings are in agreement with studies describing an age-related increase in the prevalence of MetS. 20 To expand on previous findings, we assessed whether the association between CRF and MetS differed according to age. The inverse association between higher levels of CRF and lower prevalence of MetS was most evident in younger men (54% lower likelihood) but persisted across all age groups, including those age 60-69 years (32%). Like MetS, the prevalence of obesity increased with age (table 2) . Adjusting for BMI attenuated the association between CRF and MetS but remained significant (33-34% lower) in men aged 20-49 years. The association was not statistically significant in those aged 60-69 years. Fit men of this age still had 16-17% lower risk of MetS than those who were less fit. These findings concur with previous studies that have used directly measured 8 21 CRF. The MRC Ely Study examined the association between a continuous metabolic risk score, physical activity energy expenditure (PAEE) and CRF in healthy men (54 years). 5 The robust, objective assessment of PAEE used was in contrast to the estimations of CRF from submaximal exercise. Franks et al 22 showed that the association between a metabolic risk score and PAEE was three times stronger than what it shared with CRF. While Ekelund et al 5 found a negative association between metabolic risk score and CRF, they reported that the association was no longer significant after adjusting for PAEE. The authors acknowledged the role of measurement error in their findings. Estimating CRF from submaximal exercise is associated with large random errors. Cycle ergometry may systematically underestimate CRF. Using data reported by the authors, we estimate that a healthy male, aged 54 years of age, would have a peak oxygen uptake of approximately 32±7 mL/kg/min. This value is close to our unfit group and below the normal range of values expected for men of this age. 15 Objectively measured CRF 'outperforms' physical activity 23 and more traditional cardiovascular disease risk factors as an indicator of health 7 and as a predictor of all-cause and cardiovascular mortality. 20 These studies in conjunction with our findings provide further evidence to support public health messages emphasising the importance of improving CRF for promoting cardiometabolic health. Unlike US guidelines, 24 current UK messages largely focus on the promotion of physical activity per se, and in many cases, the relatively weak association it shares with weight status and weight gain.
The greatest risk of developing metabolic abnormalities, MetS and CVD, is universally reported in individuals with the lowest CRF values. 1 25 Relatively modest increases in physical activity in adults with initially low CRF can result in observable gains in CRF associated with reductions in morbidity and mortality. 9 Current guidelines for minimum physical activity levels in adults were established, in part, on the evidence of such gains in the least fit individuals. 24 This is not to say that physical activity and BMI do not play an important role in metabolic health 12 and cardiovascular disease. 21 26 Due, however, to the difficulties in measuring physical activity and the modest reductions in BMI in response to physical activity, objectively measured CRF appears a more suitable outcome measure.
Individuals with higher fitness levels are more likely to be involved in either, or in combination, a more habitually active lifestyle and/or participate in regular structured sporting activities. The umbrella term MetS is associated with oxidative stress, inflammation and insulin resistance; it has been well established that exercise and increased physical activity are able to boost antioxidant capacity and induce anti-inflammatory effects. 27 Exercise training positively regulates fat and glucose metabolism and improves both blood pressure control and insulin action. 28 
Limitations
These data are drawn from an opportunistic sample of men attending private health screening at entry to a preventive health programme and may not be nationally representative sample. The mean area-level deprivation score for the sample was low, indicating participants lived in relatively affluent areas of the UK. MetS is positively associated with higher levels of deprivation, so the prevalence may be higher in a nationally representative sample. The fact that all participants were voluntarily participating in a preventive healthcare programme may have biased the sample either towards health conscious individuals which would likely produce a lower prevalence of MetS than expected. Alternatively, the preventive screening and healthcare may have attracted individuals with existing health concerns or those advised to improve their health by family, friends or a medical practitioner. Despite such potential biases, the sample means for health indicators such as blood pressure, BMI and the proportion of overweight and obese, are very similar to values from nationally representative samples reported as part of UK health surveillance. 29 The use of estimated peak oxygen uptake is also a limitation of the study. There are no reference data for CRF in UK adults with which to compare the present values. However, the estimates of CRF reported here are comparable with studies using expired gas analysis. 9 Age-related cut-offs 29 for low fitness are based on values approximating the 20th percentile of the reference population, the proportion of men classified as unfit (24.5%) also support the validity of our approach. 6 7 It should also be noted that the association between MetS and CRF is not markedly different between studies reporting estimated or measured peak oxygen uptake.
We defined MetS using the criteria developed by the NCEP as opposed to international criteria, 16 as most studies investigating CRF and MetS have emanated from North America. There is relatively high concordance between these criteria when applied in populations similar to the present sample. 26 We also acknowledge the cross-sectional design of the study; thus cause and effect cannot be ascertained. Furthermore, we cannot generalise our findings to the female population. Finally, we did not adjust for variations in dietary intake which may have acted to confound the associations.
CONCLUSION
The value of assessing CRF in asymptomatic adults is well established, yet CRF remains absent from UK health surveillance and screening. The negative association between CRF and metabolic risk is well established as is the age-related increase in MetS.
The present study demonstrated the expected increase in MetS prevalence associated with advancing age. Across the age-strata studied (20-69 years), prevalence was 32-53% lower in those men with good CRF ('Fit'). The association between CRF and MetS is stronger in younger men and, while it weakens with age, the association between CRF and MetS remains independent of BMI for men aged 20-49 years. Public health messages should emphasise the importance of improving CRF alongside weight management for enhancing cardiometabolic health. Inclusion of CRF assessments in UK health screening would provide greater insight into the metabolic health of asymptomatic men.
Key messages
What is already known on this subject? There is a strong association between high levels of cardiorespiratory fitness (CRF) and reduced risk of all-cause and cardiovascular mortality; these data mainly emanate from large North American databases. However, the associations of CRF with increasing age and changes in body composition with ageing have yet to be determined.
What might this study add?
In the largest study of its type in a UK population, we have shown that the prevalence of MetS is approximately one quarter of apparently healthy British men. Across increasing age strata (20-69 years), the prevalence of MetS was 32-53% lower in those men with good CRF ('Fit'). The association between CRF and MetS is stronger in younger men and, while it weakens with age, the association remains independent of BMI for men aged <50 years.
How might this impact on clinical practice?
Public health messages should advocate the need for improving CRF alongside weight management for enhancing cardiometabolic health. Inclusion of CRF assessments in UK health screening would provide greater insight into individualised metabolic health.
Twitter Follow Michelle Mellis at @mgmellis
